Milestone Pharmaceuticals (MIST) Current Assets (2018 - 2026)

Milestone Pharmaceuticals' Current Assets history runs 9 years deep, the most recent figure standing at $192.3 million for Q1 2026.

• Quarterly Current Assets rose 217.9% year-over-year to $192.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $192.3 million (up 217.9% YoY) and the FY2025 annual result came in at $111.9 million, up 51.4% from the prior year.
• Current Assets was $192.3 million for Q1 2026 at Milestone Pharmaceuticals, up from $111.9 million in the prior quarter.
• Across five years, Current Assets topped out at $192.3 million in Q1 2026 and bottomed at $46.2 million in Q2 2025.
• A 5-year average of $90.9 million and a median of $86.7 million in 2025 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2025 — Current Assets plunged 47.15% — and 2026, when it surged 217.9%.
• Milestone Pharmaceuticals' Current Assets stood at $71.8 million in 2022, then grew by 1.71% to $73.0 million in 2023, then gained by 1.22% to $73.9 million in 2024, then jumped by 51.4% to $111.9 million in 2025, then surged by 71.78% to $192.3 million in 2026.
• Business Quant data shows MIST's Current Assets at $192.3 million in Q1 2026, $111.9 million in Q4 2025, and $86.7 million in Q3 2025.